Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the presentation of two abstracts at Obesity Week 2024, the annual meeting of The Obesity Society.

the annual meeting of The Obesity Society. The first abstract comprises outcomes data from Allurion’s largest real-world cohort on record. The data, gathered from 19,428 patients across 72 ...

The drugmaker hopes to show CagriSema leads to at least 25% weight loss, without increased side effects. Its lead in a ...

Learn about research at MSK that finds obesity can influence driver mutations that produce specific subtypes of cancers, ...

One in 8 people around the world suffer from obesity, according to the World Health Organization. In the United States 74% of ...

While the study found no concrete reasoning for this change in quality of life, one factor may be the increase in obesity ...

The UK has a very capable food industry from farm to fork; But Dr Clive Black believes it’s not getting the support it ...

For the first time in decades, the prevalence of obesity has not increased in the USA, according to the latest National Health and Nutrition Examination Survey from the US Centers for Disease Control ...

Low back pain is the leading cause of disability in the world, with over 600 million people ... directly address three major ...

“Obesity in anyone and especially for pregnant ... faster recovery discharge. Arthritis patients across the world lead a better quality of life with restored joint mobility,” signs off Dr ...